Table 2.
Plasmids used in this study.
| Name | Description | Source |
|---|---|---|
| pRSII425 | LEU2, 2μ (multicopy) | [65] |
| pRSII426 | URA3, 2μ (multicopy) | [65] |
| pFB022 | pRS426 (URA3, 2μ) derivative with Lyp1YPet under ADH1 promoter | [62] |
| pFB023 | pFB022 derivative containing Lyp1(62-590)YPet | [62] |
| pSR053 | pFB023 derivative containing Lyp1(62-590) | This study |
| pSR045 | pFB022 derivative containing Agp1YPet | This study |
| pSR046 | pFB022 derivative containing Bap2YPet | This study |
| pSR047 | pFB022 derivative containing Dip5YPet | This study |
| pSR048 | pFB022 derivative containing Gnp1YPet | This study |
| pSR049 | pFB022 derivative containing Put4YPet | This study |
| pSR050 | pFB022 derivative containing Tat2YPet | This study |
| pSR051 | pFB022 derivative containing Can1YPet | This study |
| pSR057 | pRSII425 derivative containing Lyp1(62-590) under ADH1 promoter | This study |
| pYES2-PACT1-pHluorin | pYES2 (URA3, 2μ) derivative with pHluorin under ACT1 promoter | [66] |